Relates to coverage of primary and preventive obstetric and gynecological care.
Summary
Bill A05939 seeks to amend the New York insurance law to enhance coverage for primary and preventative obstetric and gynecological care. Key provisions include the removal of annual deductibles and coinsurance for certain preventive services, ensuring that coverage for cervical cancer screenings and contraceptive drugs is more accessible. The bill also introduces a rider option for contraceptive coverage in group policies, allowing enrollees to purchase this coverage directly if their group policyholder opts out.
Impact
If enacted, this bill would significantly alter the landscape of health insurance coverage for obstetric and gynecological services in New York. It would ensure that individuals with insurance have access to essential preventive care without the burden of deductibles or coinsurance, potentially increasing the utilization of these services. This change could lead to better health outcomes for individuals who require regular gynecological care and screenings, aligning state laws more closely with federal standards for preventive health services.
Sentiment
The sentiment surrounding Bill A05939 appears to be generally supportive among advocates for women's health and preventive care. Discussions suggest a recognition of the importance of accessible healthcare services, although no specific voting history or committee discussions are available to gauge opposition or detailed concerns.
Contention
Notable points of contention may arise from religious organizations or groups that oppose contraceptive coverage on moral grounds. The bill allows for exemptions based on religious tenets, which may lead to debates about the balance between individual healthcare rights and religious freedoms. This aspect could be a focal point for opposition from certain advocacy groups.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions. (Formerly HSB 25.) Effective date: 03/28/2025.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See SF 305.)
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See HF 182.)